Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Randomized Controlled Trial
100%
Allopurinol
100%
Peripheral Arterial Disease
100%
Placebo
40%
Exercise Capacity
40%
SF-36 Questionnaire
40%
Oxidative Stress
20%
Active Treatment
20%
Angina
20%
Randomized Controlled Clinical Trial
20%
6-minute Walk Distance (6MWD)
20%
Twice Daily
20%
Flow-mediated Dilation
20%
Treadmill Test
20%
Intermittent Claudication
20%
Clinical Trial Participant
20%
Walkability
20%
Maximum Walking Distance
20%
Wastage
20%
Walking Impairment Questionnaire
20%
Leg Pain
20%
Oxidized Low-density Lipoprotein (ox-LDL)
20%
Uric Acid Levels
20%
Blood Vessel Function
20%
Coronary Arterial Disease
20%
Medicine and Dentistry
Randomized Controlled Trial
100%
Arteriosclerosis Obliterans
100%
Allopurinol
100%
Placebo
40%
Exercise
40%
Walking Distance
40%
Oxidative Stress
20%
Angina pectoris
20%
Controlled Clinical Trial
20%
Artery Disease
20%
Oxidized Low Density Lipoprotein
20%
Short Form 36
20%
Intermittent Claudication
20%
Flow Mediated Dilatation
20%
Uric Acid
20%
Blood Vessel Function
20%
Walking Ability
20%
Leg Pain
20%
Diseases
20%
Active Treatment
20%
Nursing and Health Professions
Peripheral Occlusive Artery Disease
100%
Allopurinol
100%
Placebo
40%
Exercise
40%
Short Form 36
20%
Artery Disease
20%
Intermittent Claudication
20%
Uric Acid
20%
Dilatation
20%
Leg Pain
20%
Oxidized Low Density Lipoprotein
20%
Maximum Walking Distance
20%
Diseases
20%
Clinical Trial
20%
Oxidative Stress
20%
Walking Distance
20%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Allopurinol
100%
Peripheral Occlusive Artery Disease
100%
Placebo
40%
Controlled Clinical Trial
20%
Artery Disease
20%
Oxidized Low Density Lipoprotein
20%
Uric Acid
20%
Intermittent Claudication
20%
Leg Pain
20%
Diseases
20%